| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-05 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |